Literature DB >> 1977739

Postural hypotension in chronically medicated schizophrenics.

H Silver1, H Kogan, D Zlotogorski.   

Abstract

Blood pressure readings at rest and on standing in 196 chronic schizophrenic patients on stable long-term antipsychotic treatment were compared with those in unmedicated healthy controls. Patients recorded significantly lower resting blood pressure and significantly higher prevalence of postural hypotension than controls. The prevalence of postural hypotension in patients was 77% at 1 minute and 16.8% at 3 minutes after standing compared with absence of postural hypotension in controls at both time points. Prevalence of postural hypotension was unaffected by age or sex and was poorly correlated with drug dose, except in young patients. alpha 1-Receptor binding affinity of antipsychotic drugs was not predictive of postural hypotension. The possible significance of such persistent postural hypotension in chronically medicated patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977739

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.

Authors:  James J Gugger
Journal:  CNS Drugs       Date:  2011-08       Impact factor: 5.749

Review 2.  Cardiovascular adverse effects of antipsychotic drugs.

Authors:  N A Buckley; P Sanders
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

3.  Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

Authors:  Z Nourian; T Mow; D Muftic; S Burek; M L Pedersen; J Matz; M J Mulvany
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

Review 4.  Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.

Authors:  S Grant; A Fitton
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

5.  Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study.

Authors:  Fuminari Misawa; Keiko Shimizu; Yasuo Fujii; Ryouji Miyata; Fumio Koshiishi; Mihoko Kobayashi; Hirokazu Shida; Yoshiyo Oguchi; Yasuyuki Okumura; Hiroto Ito; Mami Kayama; Haruo Kashima
Journal:  BMC Psychiatry       Date:  2011-07-26       Impact factor: 3.630

6.  The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Andre S Pupo; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2020-08

7.  Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications.

Authors:  Giulia Rivasi; Martina Rafanelli; Enrico Mossello; Michele Brignole; Andrea Ungar
Journal:  Drugs Aging       Date:  2020-10       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.